High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households
Matthieu Fritz, Béatrice Rosolen, Émilie Krafft, Pierre Becquart, Éric Elguero, Oxana Vratskikh, Solène Denolly, Bertrand Boson, Jessica Vanhomwegen, Meriadeg Ar Gouilh, Angéli Kodjo, Catherine Chirouze, Serge G. Rosolen, Vincent Legros, Eric M. Leroy
Abstract
In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.
Topics & Concepts
SeroprevalenceCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyBetacoronavirusVeterinary medicineCATSAntibodyMedicineEnvironmental healthCoronavirus InfectionsBiologyImmunologySerologyOutbreakInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies